204 related articles for article (PubMed ID: 17300634)
1. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.
Brieger WR; Okeibunor JC; Abiose AO; Ndyomugyenyi R; Kisoka W; Wanji S; Elhassan E; Amazigo UV
Trop Med Int Health; 2007 Feb; 12(2):260-8. PubMed ID: 17300634
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
3. Untreated villages and factors associated with the absence of Community-Directed Treatment with Ivermectin (CDTI) in DRC.
Makenga Bof JC; Ntumba Tshitoka F; Mpunga Mukendi D; Mansiangi Mankadi P; Ilunga-Ilunga F; Coppieters Y
J Infect Dev Ctries; 2018 Sep; 12(9):771-779. PubMed ID: 31999636
[TBL] [Abstract][Full Text] [Related]
4. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
5. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
6. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
8. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
Brieger WR; Okeibunor JC; Abiose AO; Wanji S; Elhassan E; Ndyomugyenyi R; Amazigo UV
Parasit Vectors; 2011 Jul; 4():152. PubMed ID: 21794139
[TBL] [Abstract][Full Text] [Related]
9. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
10. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
11. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
[TBL] [Abstract][Full Text] [Related]
13. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
York KJ; Kabole I; Mrisho M; Berry DM; Schmidt E
J Nurs Scholarsh; 2015 Jan; 47(1):96-104. PubMed ID: 25565278
[TBL] [Abstract][Full Text] [Related]
15. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
Makenga Bof JC; Maketa V; Bakajika DK; Ntumba F; Mpunga D; Murdoch ME; Hopkins A; Noma MM; Zouré H; Tekle AH; Katabarwa MN; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):48-62. PubMed ID: 25302560
[TBL] [Abstract][Full Text] [Related]
16. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
Noma M; Zouré HG; Tekle AH; Enyong PA; Nwoke BE; Remme JH
Parasit Vectors; 2014 Jul; 7():325. PubMed ID: 25053266
[TBL] [Abstract][Full Text] [Related]
17. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
19. Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study.
Bhwana D; Amaral LJ; Mhina A; Hayuma PM; Francis F; Siewe Fodjo JN; Mmbando BP; Colebunders R
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011178. PubMed ID: 37379350
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
Weldegebreal F; Medhin G; Weldegebriel Z; Legesse M
BMC Res Notes; 2016 Apr; 9():206. PubMed ID: 27053243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]